Semperit: Just under EUR 50 million impairment loss at Sempermed – annual result negative

17.12.2019 (Press information)

Vienna, Austria, 17 December 2019 – The Executive Board of the Semperit AG Holding today quantified the impairment loss in the Medical Sector (Sempermed segment) at just under EUR 50 million. The earnings after taxes for Q1-3 2019 are expected to be around EUR –35 million; the annual result will be negative as well.

As announced in the ad-hoc release on 13 November 2019, the publication of the interim Group report as of 30 September was postponed. The publication date was now set for 19 December 2019.

Contact:

Monika Riedel
Director Group Communications & Sustainability
+43 676 8715 8620

Judit Helenyi
Head of Investor Relations
+43 676 8715 8310

www.semperitgroup.com
www.facebook.com/SemperitAGHolding
https://twitter.com/semperitgroup

About Semperit:
The publicly listed company Semperit AG Holding is an internationally-oriented group that develops, produces, and sells in more than 100 countries highly specialised rubber products for the medical and industrial sectors: examination and surgical gloves, hydraulic and industrial hoses, conveyor belts, escalator handrails, construction profiles, cable car rings, and products for railway superstructures. The headquarters of this long-standing Austrian company, which was founded in 1824, are located in Vienna. The Semperit Group employs around 7,100 people worldwide, including about 3,800 in Asia and around 900 in Austria (Vienna and production site in Wimpassing, Lower Austria). The Group has 14 manufacturing facilities worldwide and numerous sales offices in Europe, Asia, Australia, and America. In 2018, the group generated revenue of EUR 878.5 million and an adjusted EBITDA (without one-off effects) of EUR 50.3 million.


Contact

Monika Riedel
Director Group Brand Management, Corporate Spokesperson
T +43 1 79777-620